This website is for US healthcare professionals

close-icon

Log In to Bolder Science

or

Don't have an account? Sign Up

close-icon

Please enter your email address.

You will receive a link to create a new password via email.

Log In

close-icon

Create an Account

or
  • 8 characters minimum
  • First character may not be a number
  • Last character may not be a number
close-icon

Welcome and thank you for creating an account!

At Bolder Science, we want your clinical trial search experience to be the best it can be. Complete the following prompts to easily find the trials you are interested in and see trials recruiting near you. You can adjust these selections in your dashboard after creating your account.

Condition Categories

Condition categories are pulled directly from ClinicalTrials.gov. Choose 1 or more condition categories that you are interested in:

Clinical Trials of Interest

When I’m looking for information on clinical trials, I usually am interested in...

Set a default location

Guided Imagery & Music in Cancer

  • Clinicaltrials.gov identifier

    NCT03936075

  • Recruitment Status

    Active, not recruiting

  • First Posted

    May 3, 2019

  • Last update posted

    July 8, 2020

Study Description

Brief summary:

This is an RCT pilot study to explore the potential effects of the Guided Imagery & Music method for women with breast or gynecologic cancer, during active treatment. The study explores the potential impact in quality of life parameters such as mood, fatigue, and hope.

  • Condition or Disease:Cancer Ovaries
    Cancer Uterus Cervix
    Cancer, Breast
    Cancer, Metastatic
  • Intervention/Treatment: Behavioral: the Guided Imagery and Music method
    Behavioral: standard care and verbal counselling
  • Phase: N/A

Detailed Description

Guided Imagery and Music is a music-assisted psychotherapy method which has been used as a complementary, supportive psychosocial therapy in cancer care. However, its effects have never been explored during the period of active chemotherapy or radiotherapy treatment in various cancer populations, and especially gynecologic and breast cancer. This pilot study is an effort to explore the feasibility of the method to increase quality of life in this population by possibly reducing side-effects of treatment such as fatigue, improving mood, and building resilience as expressed through levels of hope.

Study Design

  • Study Type: Interventional
  • Actual Enrollment: 20 participants
  • Allocation: Randomized
  • Intervention Model: Parallel Assignment
  • Intervention Model Description: two randomised groups, one intervention group and one placebo group
  • Masking: Double (Participant, Care Provider)
  • Primary Purpose: Supportive Care
  • Official Title: Guided Imagery & Music in Active Treatment for Gynecologic or Breast Cancer: An RCT Pilot
  • Actual Study Start Date: July 2018
  • Estimated Primary Completion Date: June 2020
  • Actual Study Completion Date: December 2020

Arms and interventions

Arm Intervention/treatment
Experimental: intervention
treatment with the provision of 6 individual sessions of the Guided Imagery and Music method as a psychological supportive intervention, and psychometric questionnaires collection
Behavioral: the Guided Imagery and Music method
the method involves listening to the music while describing the experience to the therapist, any visual imagery that is evoked by the music, emotions, body sensations, thoughts or memories. after the music listening session, there is discussion upon making meaning of the experience and finding resources as potential coping skills
Placebo Comparator: control
standard care treatment with psychometric questionnaires collection and two individual counselling sessions, at baseline (week 1) and at the end (week 6)
Behavioral: standard care and verbal counselling
the participants receive their usual cancer treatment and two individual counselling sessions

Outcome Measures

  • Primary Outcome Measures: 1. Profiles of Mood States (POMS) Brief version (adapted) [ Time Frame: Baseline and up to 12 weeks (post-intervention) ]
    Brief version adapted in Greek. A 30-item scale designed to assess six different moods namely tension, anger, vigor, fatigue, depression, confusion. It requires to indicate mood state over the last week, with a single word, each item ranging from 0(not at all) to 4 (extremely). The questionnaire is a sum of its 6 sub scales (each addressing the aforementioned moods), with a total score from 0 to 120. Lower scores indicate better mood states.
  • Secondary Outcome Measures: 1. Herth Hope Index [ Time Frame: Baseline and up to 12 weeks (post-intervention) ]
    A 12-item Likert-format instrument assessing current levels of hope from 1(strongly disagree) to 4 (strongly agree). It consists of three sub scales, examining interconnectedness, temporality and spirituality, and positiveness or expectancy. A higher score of the sum or the 3 sub scales indicates a higher hope level with scores ranging from 12 to 48.
  • 2. Cancer-related Fatigue Scale (CFS) [ Time Frame: Baseline and up to 12 weeks (post-intervention) ]
    An instrument consisting of 15 items that assess physical, affective, and cognitive dimensions of fatigue at present moment, with Likert scales ranging from 1 to 5. the physical sub scale consists of 7 items, the affective sub scale consists of 4 items, and the cognitive sub scale consists of 3 items and the total of all 3 sub scales indicate that greater scores correspond to greater fatigue levels.
  • 3. Visual Analogue Scale for Hope (VAS-H) [ Time Frame: obtained 6 times throughout the completion of intervention (up to 12 weeks) ]
    VAS is a single, frequent measurement to address the current levels of hope. Its s based on a 100cm horizontal line from 1cm (hopeless) to 100cm (hopeful)
  • 4. Visual Analogue Scale for Fatigue (VAS-F) [ Time Frame: Obtained 6 times throughout the completion of intervention (up to 12 weeks) ]
    VAS is a single, frequent measurement to address the current levels of fatigue.

Eligibility Criteria

  • Ages Eligible for Study: 18 to 75 Years (Adult, Older Adult)
  • Sexes Eligible for Study: Female
  • Accepts Healthy Volunteers: No

Criteria

Inclusion Criteria:

- Speaking Greek

- receiving chemotherapy or radiotherapy treatment for breast or gynecologic cancer

- first occurrence or metastatic

- have an interest in engaging in creative psychotherapies through music

Exclusion Criteria:

- women with active psychosis or PTSD symptomatology

- women receiving other psychological support

- women too ill to participate according to doctors' instructions

Contacts and Locations

Contacts

Locations

Greece, Attiki
Aretaieion University Hospital
Athens

Sponsors and Collaborators

Aalborg University

Aretaieion University Hospital

SONORA Organisation for Music Therapy and Research

Investigators

Study Director: Niels Hannibal, PhD Aalborg University

More Information

  • Responsible Party: Aalborg University
  • ClinicalTrials.gov Identifier: NCT03936075 History of Changes
  • Other Study ID Numbers: 62/19-06-18
  • First Posted: May 3, 2019 Key Record Dates
  • Last Update Posted: July 8, 2020
  • Last Verified: July 2020
  • Studies a U.S. FDA-regulated Drug Product: No
  • Studies a U.S. FDA-regulated Device Product: No
  • Keywords provided by Aalborg University: Guided Imagery & Music (GIM)
    gynecologic cancer
    breast cancer
    receptive music therapy
    chemotherapy
    radiotherapy
  • Additional relevant MeSH terms: Breast Neoplasms